OA08469A - Dérivés de benzazécine. - Google Patents

Dérivés de benzazécine.

Info

Publication number
OA08469A
OA08469A OA59052A OA59052A OA08469A OA 08469 A OA08469 A OA 08469A OA 59052 A OA59052 A OA 59052A OA 59052 A OA59052 A OA 59052A OA 08469 A OA08469 A OA 08469A
Authority
OA
OAPI
Prior art keywords
chloro
cpds
acetyl
benzazecine
methoxybenzoyl
Prior art date
Application number
OA59052A
Other languages
English (en)
French (fr)
Inventor
Werner Aschwanden
Rene Imhof
Roland Jakob
Emilio Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of OA08469A publication Critical patent/OA08469A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
    • C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D227/08—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
OA59052A 1986-01-23 1987-01-23 Dérivés de benzazécine. OA08469A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH26686 1986-01-23

Publications (1)

Publication Number Publication Date
OA08469A true OA08469A (fr) 1988-07-29

Family

ID=4183090

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59052A OA08469A (fr) 1986-01-23 1987-01-23 Dérivés de benzazécine.

Country Status (30)

Country Link
US (4) US4732979A (cs)
EP (1) EP0230967B1 (cs)
JP (1) JPS62169770A (cs)
KR (1) KR910000659B1 (cs)
CN (1) CN1013111B (cs)
AT (1) ATE68790T1 (cs)
AU (1) AU590042B2 (cs)
CS (1) CS258147B2 (cs)
DD (1) DD264431A5 (cs)
DE (1) DE3773950D1 (cs)
DK (1) DK35887A (cs)
FI (1) FI82931C (cs)
GB (1) GB2185744B (cs)
HU (1) HU197883B (cs)
IE (1) IE870167L (cs)
IL (1) IL81317A (cs)
IS (1) IS3190A7 (cs)
MC (1) MC1795A1 (cs)
MT (1) MTP996B (cs)
MW (1) MW187A1 (cs)
NO (1) NO167385C (cs)
NZ (1) NZ218987A (cs)
OA (1) OA08469A (cs)
PH (1) PH22879A (cs)
PL (1) PL263796A1 (cs)
PT (1) PT84181B (cs)
TN (1) TNSN87006A1 (cs)
YU (1) YU7087A (cs)
ZA (1) ZA87407B (cs)
ZW (1) ZW1087A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82931C (fi) * 1986-01-23 1991-05-10 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensazecinderivat.
IN167395B (cs) * 1987-07-21 1990-10-20 Hoffmann La Roche
EP0591583B1 (en) * 1991-08-21 2001-12-19 Eli Lilly And Company Benzo (f) quinolinones as 5-alpha-reductase inhibitors
ES2125884T3 (es) * 1991-08-21 1999-03-16 Lilly Co Eli Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
WO1994022444A1 (en) * 1993-03-29 1994-10-13 Smithkline Beecham Corporation Tricyclic compounds for inhibiting platelet aggregation
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
KR970706271A (ko) 1994-09-20 1997-11-03 스티븐슨 린다 에스. 시냅스 전달 향상용 약제(drugs to improve synaptic transmission)
US20050067341A1 (en) * 2003-09-25 2005-03-31 Green Dennis H. Continuous production membrane water treatment plant and method for operating same
US7094331B2 (en) * 2003-11-05 2006-08-22 Marathon Ashland Petroleum Llc Viscosity modification of heavy hydrocarbons using dihydric alcohols
US20090263439A1 (en) * 2008-04-18 2009-10-22 The Procter & Gamble Company Antimicrobial Preservative Free Wipe
CN106117028B (zh) * 2016-06-14 2019-01-01 浙江永太药业有限公司 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE442586A (cs) * 1940-07-31
JPS5129710B2 (cs) * 1972-09-09 1976-08-27
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
US4521423A (en) * 1983-10-31 1985-06-04 Ayerst, Mckenna & Harrison, Ltd. 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them
FI82931C (fi) * 1986-01-23 1991-05-10 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensazecinderivat.

Also Published As

Publication number Publication date
IE870167L (en) 1987-07-23
DE3773950D1 (de) 1991-11-28
US4732979A (en) 1988-03-22
NO870280D0 (no) 1987-01-22
MW187A1 (en) 1987-10-14
US4957911A (en) 1990-09-18
FI82931B (fi) 1991-01-31
ATE68790T1 (de) 1991-11-15
FI870220A0 (fi) 1987-01-20
JPS62169770A (ja) 1987-07-25
PT84181B (pt) 1989-09-14
ZW1087A1 (en) 1987-08-12
GB2185744A (en) 1987-07-29
NO870280L (no) 1987-07-24
MTP996B (en) 1987-08-21
YU7087A (en) 1988-06-30
ZA87407B (en) 1987-09-30
GB2185744B (en) 1989-12-06
CN1013111B (zh) 1991-07-10
CN87100312A (zh) 1987-09-09
AU590042B2 (en) 1989-10-26
PH22879A (en) 1989-01-19
DK35887D0 (da) 1987-01-22
CS258147B2 (en) 1988-07-15
PL263796A1 (en) 1988-10-27
GB8701416D0 (en) 1987-02-25
US4876340A (en) 1989-10-24
AU6791187A (en) 1987-07-30
HU197883B (en) 1989-06-28
CS41887A2 (en) 1987-11-12
KR870007132A (ko) 1987-08-17
DK35887A (da) 1987-07-24
EP0230967B1 (de) 1991-10-23
MC1795A1 (fr) 1987-10-22
IL81317A (en) 1991-06-30
NO167385C (no) 1991-10-30
NO167385B (no) 1991-07-22
EP0230967A2 (de) 1987-08-05
FI870220A7 (fi) 1987-07-24
EP0230967A3 (en) 1988-08-31
IL81317A0 (en) 1987-08-31
DD264431A5 (de) 1989-02-01
NZ218987A (en) 1990-04-26
US4749791A (en) 1988-06-07
KR910000659B1 (ko) 1991-01-31
IS3190A7 (is) 1987-07-24
HUT44519A (en) 1988-03-28
TNSN87006A1 (fr) 1990-01-01
FI82931C (fi) 1991-05-10
PT84181A (pt) 1987-02-01

Similar Documents

Publication Publication Date Title
ATE68790T1 (de) Benzazecin-derivate.
LU90219I2 (fr) Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR)
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
LU88822I2 (fr) Stavudine et ses dérivés pharmaceutiquement acceptables (Zerit R)
FI892675A0 (fi) 2,6-dihalogenpyridin-3 -karboxylsyraderivat och deras framstaellning.
SE8704979D0 (sv) New furanuronic acid derivatives, process for their production and their use
FI884345A0 (fi) Sackaridderivat.
NO911798L (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
BG35031A3 (bg) Метод за получаване на 1,1,2-трифенилпропанови (пропенови) производни
FI901459A0 (fi) In vitro-syntes av ingripande rna.
ES2059097T3 (es) Derivados de la ergolina.
ES8708226A1 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina
GR880100196A (el) Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους
RO96381A2 (ro) Procedeu pentru sinteza azobisciclopentancarbonitrilului
NO921313L (no) Derivater av 2-spirocyklopropylcefalosporinsulfoner og deres fremstilling